Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys

Histology and Histopathology

Volumn 27, Issue 1, 2012, Pages 89-94

  Heman, Paola ^a,c   Barcia, Carlos ^a,b   Gómez, Aurora ^a,b   Ros, Carmen M ^a,b   Ros Bernal, Francisco ^a,b   Yuste, José Enrique ^a,b   de Pablos, Vicente ^a,b   Fernandez Villalba, Emiliano ^a,b   Toledo Cárdenas, María Rebeca ^c   Herrero, María Trinidad ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

c Fos; Cerebellum; MPTP; Parkinson's disease; Purkinje cells

Indexed keywords

DOPAMINE; PROTEIN C FOS;

ANIMAL; ARTICLE; CEREBELLUM; CHRONIC DISEASE; DISEASE MODEL; FEMALE; INTOXICATION; MACACA; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; PURKINJE CELL; SUBSTANTIA NIGRA;

ANIMALS; CEREBELLUM; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; MACACA; MALE; MPTP POISONING; ORGAN SIZE; PROTO-ONCOGENE PROTEINS C-FOS; PURKINJE CELLS; SUBSTANTIA NIGRA;

EID: 82755189023     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Barcia C., Bautista V., Sanchez-Bahillo A., Fernandez-Villalba E., Navarro-Ruis J.M., Barreiro A.F., Poza y Poza M. and Herrero M.T. (2003). Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys. Neuroendocrinology 78, 118-128.
2. Barcia C., Sanchez Bahillo A., Fernandez-Villalba E., Bautista V., Poza y Poza M., Fernandez-Barreiro A., Hirsch E.C. and Herrero M.T. (2004). Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 46, 402-409.
3. Barcia C., Ros C.M., Annese V., Gómez A., Ros-Bernal F., Aguado-Yera D., Martínez-Pagán M.E., de Pablos V., Fernandez-Villalba E. and Herrero M.T. (2011). IFN-aasignaling, with the synergistic contribution of TNF-c, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis. 7, 2-e142.
4. Cerasa A., Hagberg G.E., Peppe A., Bianciardi M., Gioia M.C., Costa A., Castriota-Scanderbeg A., Caltagirone C. and Sabatini U. (2006). Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease. Brain Res. Bull. 71, 259-269.
5. Chen J.Y., Hsu P.C., Hsu I.L. and Yeh G.C. (2001). Sequential upregulation of the c-Fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57bl/6 mice. Neurosci. Lett. 314, 49-52.
6. 2+, camp-responsive element binding proteins, and mitogenactivated protein kinase signaling. J. Neurosci. 17, 7252-7266.
7. Fortin M., Marchand R. and Parent A. (1998). Calcium-binding proteins in primate cerebellum. Neurosci. Res. 30, 155-168.
8. Gundersen H.J. (1986). Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J. Microsc. 143, 3-45.
9. Herrero M.T., Hirsch E.C., Kastner A., Ruberg M., Luquin M.R., Laguna J., Javoy-Agid F., Obeso J.A. and Agid Y. (1993). Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 56, 499-511.
10. Luckman S.M., Dyball R.E. and Leng G. (1994). Induction of c-Fos expression in hypothalamic magnocellular neurons requires synaptic activation and not simply increased spike activity. J. Neurosci. 14, 4825-4830.
11. Necchi D., Soldani C., Ronchetti F., Bernocchi G. and Scherini E. (2004). MPTP-induced increase in c-Fos-and c-jun-like immunoreactivity in the monkey cerebellum. Eur. J. Histochem. 48, 385-392.
12. Paxinos G., Huang X.F. and Toga A.W. (2000). The rhesus monkey brain in stereotaxic coordinates. Academic Press. San Diego.
13. Rascol O., Sabatini U., Fabre N., Brefel C., Loubinoux I., Celsis P., Senard J.M., Montastruc J.L. and Chollet F. (1997). The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain 120, 103-110.
14. Rolland A.S., Herrero M.T., Garcia-Martinez V., Ruberg M., Hirsch E.C. and François C. (2007). Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism. Brain 130, 265-75.
15. Takada M., Sugimoto T. and Hattori T. (1993). MPTP neurotoxicity to cerebellar purkinje cells in mice. Neurosci. Lett. 150, 49-52.
16. Vignola C., Nechi D., Scherini E. and Bernocchi G. (1994). MPTPinduced changes in the monkey cerebellum. Immunohistochemistry of calcium binding and cytoskeletal proteins. Neurodegeneration 3, 25-31.
17. Yu H., Sternad D., Corcos D.M. and Vaillancourt D.E. (2007). Role of hyperactive cerebellum and motor cortex in Parkinson's disease. Neuroimage 35, 222-233.